Sheppard Mullin Represented US Pharma Lab in Successful Sale to Biofarma Group
Sheppard Mullin advised US Pharma Lab, a leading, fast-growing and innovative Contract Development and Manufacturing Organization (“CDMO”), in its acquisition by Biofarma Group, an Italian and European market leader in the development, manufacturing and packaging of dietary supplements. The acquisition was first announced in May 2023, and marks the first global CDMO focused on nutraceuticals.
The Sheppard Mullin deal team that represented US Pharma Lab was led by partner Ariel Yehezkel and included special counsel Amanda Ackerman, attorney Patrick Hao and associate Allison Troianos. Tax aspects of the transaction were led by partners Josh McLane and John Crisp, with invaluable assistance from many other specialists.
Click here to read the press release.